Sign in

CIK 0001124105

  • Accelerated filer
  • Smaller reporting company

GYRE THERAPEUTICS, INC.

Sign in to watch
Ticker
GYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
562020050
Phone
+1 858-284-0115
Business address
12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
Former names
CATALYST BIOSCIENCES, INC., TARGACEPT INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-07-30 Payne Fletcher Chief Financial Officer Grant or award · Stock Option (Right to Buy) +25,000 25,000
2018-07-30 Levy Howard Chief Medical Officer Grant or award · Stock Option (Right to Buy) +35,000 35,000
2018-06-13 Williams Eddie Director Grant or award · Stock Option (Right to Buy) +5,000 5,000
2018-06-13 Richard John P Director Grant or award · Stock Option (Right to Buy) +5,000 5,000
2018-06-13 LAWLOR AUGUSTINE Director Grant or award · Stock Option (Right to Buy) +5,000 5,000
2018-06-13 Hunt Andrea Director Grant or award · Stock Option (Right to Buy) +5,000 5,000
2018-06-13 HILL STEPHEN A Director Grant or award · Stock Option (Right to Buy) +5,000 5,000
2018-06-13 DESOUZA ERROL B Director Grant or award · Stock Option (Right to Buy) +5,000 5,000
2018-05-03 Levy Howard Chief Medical Officer Exercise or conversion +7,560 $4.63 $35K 7,560
2018-05-03 Levy Howard Chief Medical Officer Exercise or conversion · Stock Option (Right to Buy) −7,560 87,440
2018-04-09 USMAN NASSIM President & CEO Gift −88 0
2018-04-09 USMAN NASSIM President & CEO Gift +88 4,144
2018-04-04 USMAN NASSIM President & CEO Exercise or conversion +88 $4.63 $407 88
2018-04-04 USMAN NASSIM President & CEO Exercise or conversion · Stock Option (Right to Buy) −88 274,912
2018-03-26 Payne Fletcher Chief Financial Officer Exercise or conversion +59 $4.63 $273 59
2018-03-26 Payne Fletcher Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) −59 74,941
2018-03-08 Flynn James E 10% owner Sale −866 $30.00 $26K 813,147
2018-03-08 Flynn James E 10% owner Sale −328 $30.00 $10K 308,198
2018-03-08 Flynn James E 10% owner Sale −5,890 $29.03 $171K 807,257
2018-03-08 Flynn James E 10% owner Sale −2,233 $29.03 $65K 305,965

Page 20 of 24 · 471 trades